Retinoid X receptor

retinoid X receptor alpha
Identifiers
SymbolRXRA
NCBI gene6256
HGNC10477
OMIM180245
RefSeqNM_002957
UniProtP19793
Other data
LocusChr. 9 q34
Search for
StructuresSwiss-model
DomainsInterPro
retinoid X receptor beta
Identifiers
SymbolRXRB
NCBI gene6257
HGNC10478
OMIM180246
RefSeqNM_021976
UniProtP28702
Other data
LocusChr. 6 p21.3
Search for
StructuresSwiss-model
DomainsInterPro
retinoid X receptor gamma
Identifiers
SymbolRXRG
NCBI gene6258
HGNC10479
OMIM180247
RefSeqNM_006917
UniProtP48443
Other data
LocusChr. 1 q22-q23
Search for
StructuresSwiss-model
DomainsInterPro

The retinoid X receptor (RXR) is an important family of transcription factors that can combine with various nuclear receptors to form a protein dimer, which is often needed for those receptors to perform their functions. It is also a nuclear receptor which is activated by 9-cis retinoic acid, but whether its role as a direct endogenous receptor is important biologically is controversial. It can also bind to 9-cis-13,14-dihydroretinoic acid, which may be an endogenous mammalian RXR-selective agonist. Bexarotene is the only FDA-approved medication that selectively activates the RXRs while exhibiting negligible activity toward the retinoic acid receptors.

There are three retinoic X receptors (RXR): RXR-alpha, RXR-beta, and RXR-gamma, encoded by the RXRA, RXRB, RXRG genes, respectively.

RXR heterodimerizes with multiple nuclear receptors including CAR, FXR, LXR, PPAR, PXR, RAR, TR, ER and VDR. RXRs are permissive co-receptors as only one of six alleles is needed for normal development and health. Given this, it is difficult to extrapolate whether the RXR pathway has its own endogenous activity driven by 9-cis retinoic acid species or whether it merely participates in other pathways, predominantly the retinoic nuclear receptor pathway. Genomic knockout of the RXRs results in obesity resistance while bexarotene treatment causes severe hypothyroidism, suggesting that the RXR pathway functions at least to regulate the thyroid hormone receptor pathway.